Suchergebnis | Hamburg Open Science

Facetten

41 Einträge gefunden

Definition of high-risk prostate cancer impacts oncological outcomes after radical prostatectomy
2020 - Forschungsinformationssystem des UKE
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
2020 - Forschungsinformationssystem des UKE
Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence
2018 - Forschungsinformationssystem des UKE
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy
2017 - Forschungsinformationssystem des UKE
Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatment
2017 - Forschungsinformationssystem des UKE
High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy
2017 - Forschungsinformationssystem des UKE
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer:European Validation of the Current NCCN® Guideline
2017 - Forschungsinformationssystem des UKE
Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy
2016 - Forschungsinformationssystem des UKE
Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy
2016 - Forschungsinformationssystem des UKE
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion
2014 - Forschungsinformationssystem des UKE
A Feasible and Time-efficient Adaptation of NeuroSAFE for da Vinci Robot-assisted Radical Prostatectomy
2014 - Forschungsinformationssystem des UKE
Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence
2013 - Forschungsinformationssystem des UKE
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?
2013 - Forschungsinformationssystem des UKE
CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer
2013 - Forschungsinformationssystem des UKE
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.
2012 - Forschungsinformationssystem des UKE
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy
2012 - Forschungsinformationssystem des UKE
Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomy.
2012 - Forschungsinformationssystem des UKE
Full functional-length urethral sphincter preservation during radical prostatectomy.
2011 - Forschungsinformationssystem des UKE
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
2011 - Forschungsinformationssystem des UKE
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
2011 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Definition of high-risk prostate cancer impacts oncological outcomes after radical prostatectomy

A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy

Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence

Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy

Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatment

High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy

Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer:European Validation of the Current NCCN® Guideline

Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy

Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy

βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion

A Feasible and Time-efficient Adaptation of NeuroSAFE for da Vinci Robot-assisted Radical Prostatectomy

Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer

The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.

Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy

Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomy.

Full functional-length urethral sphincter preservation during radical prostatectomy.

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.